Navigation Links
Gilead's AIDS Drug Awaits Patent in India

American bio-pharmaceutical major Gilead, which has entered into generic licensing deals with 10 Indian pharma firms to distribute its HIV drug Viread, is hoping to get a patent in India soon.

"We have made considerable progress in implementing our access programme and licensed Indian pharmas to manufacture Viread which originally announced a pricing of $1 a day for the pill," Gregg Alton, senior vice president and general counsel, Gilead Sciences, told IANS.

"After much discussion, Gilead now believes that a larger number of manufacturers will intensify competition and drive down prices even further," said Alton whose team was in Delhi last week.

Now, Gilead's application for a patent is pending before the Indian Patent office as it believes that it has a right to protect its intellectual property.

Indian pharma major Cipla has filed a pre-grant opposition against the patent application for Viread before the patents office.

But Alton said: "We believe that protecting the intellectual property of companies who engage in drug research and development is a critical part of the treatment access equation. Intellectual property protection, when used responsibly, encourages research and discovery of newer and more effective molecules.

"Gilead respects Cipla's right to oppose the issuance of a patent for Viread or any drug. But more importantly, we reaffirm our desire to work with Cipla whether or not a patent is issued," said Alton.

Gilead has signed generic licensing deals with 10 Indian pharma majors to distribute Viread in India and 94 other resource-limited countries.

More than 5.1 million people are believed to be infected with HIV in India - the second highest incidence of the disease after South Africa.

According to Alton, Viread (tenofovir disoproxil fumarate) is on its way to becoming the frontrunner drug across Europe for HIV/AIDS due to
'"/>




Page: 1 2

Related medicine news :

1. Vaccine For Cervical Cancer Awaits Approval
2. India Awaits Test Results To Confirm The Bird Flu Virus In Humans
3. Three-year-old AIDS Patient Awaits Death
4. Pfizer Awaits FDA Approval for New AIDS Drug, Maraviroc
5. Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
6. HIV Patients Opposes Patenting Of AIDS Drug
7. Provigil Patent Extension Accorded To Cephalon
8. AIDS Sufferers Protest against Proposed Patent for Tenofovir
9. POLY Medicure Ltd Applies for 8 Patents, 2 FDA Approvals
10. Venus Remedies Files 5th International Patent Application
11. US Court Rules Against Lupin in Ramipril Patent Case
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gilead AIDS Drug Awaits Patent India

(Date:12/15/2014)... 2014 (HealthDay News) -- Expert pilots process visual information ... they make better decisions during landings, a new study ... techniques for pilots to master, and 36 percent of ... occur during final approach and landing. Researchers monitored ... moderately experienced pilots while they were at the controls ...
(Date:12/15/2014)... Kathy McAfee, America's Marketing Motivator, was announced a ... category of Best Blog 2014. McAfee received the top ... blog Networking Ahead which combines many different ... talent and influence through better networking, leadership and communication ... Ahead for Business, has been motivating readers for the ...
(Date:12/15/2014)... 15, 2014 In support of ... attention to restrictive state laws that may have ... this important area of public health policy. , ... the Integrity of Independent Review, contends that state ... independent peer review determinations can result in subpar ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 Bacteroides is becoming ... only is it much more prevalent than coliforms, it cannot ... in the environment. , Key Benefits of the new ... fecal contamination , Eliminates false positives from coliforms ... and Sensitivity , Maintain the same sampling ...
(Date:12/15/2014)... La Jolla, Calif. (PRWEB) December 15, 2014 ... Roasters made the Coffee Review “Top 30 Coffees of 2014.” ... number two, and their Guji Zone Ethiopia at number 10. ... list twice. , Coffee Review’s selection is ranked on ... The Sumatra Ulos Batak scored 96 out of 100, and ...
Breaking Medicine News(10 mins):Health News:Study Shows Why Expert Pilots Are Experts 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2Health News:Bird Rock Coffee Roasters Ranks Second and Tenth in Coffee Review’s ‘Top 30 Coffees of 2014’ 2
... eCare, an initiative that employs information,and advanced technologies ... care, WILLIAMSBURG, Va., June 18 The ... and Mary proudly announces that,Professor Dorothea La "Chon" ... awards available to a faculty member in a ...
... source; New York City links 7 infections to salmonella ... number of people known to have fallen ill after ... 30 states plus the District of Columbia, U.S. health ... not due to new infections but mainly because some ...
... Corporation,(Nasdaq: AIRM ), the largest air medical ... Executive Officer Aaron Todd and Chief,Financial Officer Trent ... Conference in New York City on Tuesday, June ... can listen to the presentation via a live ...
... strike small percentage of patients , , WEDNESDAY, June 18 ... new side effect associated with the cancer drug Gleevec ... leukemia and gastrointestinal stromal tumors. , In a letter ... New England Journal of Medicine , the doctors describe ...
... seizures, SPOKANE, Wash., June 18 The Epilepsy,Foundation ... this Saturday, June 21 in Spokane at Riverfront Park ... from 9:30 am - 12:30 pm., "Everyone is ... with epilepsy," said Ryan Oelrich, Program Manager. "We are ...
... Berkeley The newly sequenced genome of a dainty, quill-like ... that vertebrates evolved over the past 550 million years through ... ,The late geneticist Susumu Ohno argued in 1970 ... evolution of higher organisms, and Ohno,s theory was the basis ...
Cached Medicine News:Health News:Professor Chon Abraham of the Mason School of Business at The College of William & Mary named Fulbright Scholar 2Health News:Professor Chon Abraham of the Mason School of Business at The College of William & Mary named Fulbright Scholar 3Health News:Professor Chon Abraham of the Mason School of Business at The College of William & Mary named Fulbright Scholar 4Health News:Professor Chon Abraham of the Mason School of Business at The College of William & Mary named Fulbright Scholar 5Health News:Tainted Tomato Cases Jump to 383 People in 30 states, D.C. 2Health News:Tainted Tomato Cases Jump to 383 People in 30 states, D.C. 3Health News:Cancer Drug Gleevec Linked to Muscle Damage 2Health News:Genome sequence of lancelet shows how genes quadrupled during vertebrate evolution 2Health News:Genome sequence of lancelet shows how genes quadrupled during vertebrate evolution 3Health News:Genome sequence of lancelet shows how genes quadrupled during vertebrate evolution 4
(Date:12/17/2014)... LOS ANGELES , Dec. 17, 2014 /PRNewswire/ ... that the US Patent and Trademark Office (USPTO) ... candidate ICT-107, a dendritic cell-based immunotherapeutic vaccine targeting ... glioblastoma. The claims of US Patent No. 8,871,211, ... treating neural cancer by administering a dendritic cell ...
(Date:12/17/2014)... MARLBOROUGH, Mass. , Dec. 17, 2014 /PRNewswire/ ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today announced completion of enrollment in ... results from the 3-month observations confirmed the 1-month ... year:  Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:12/17/2014)... -- PCCA received the Autism Hope Alliance,s (AHA) ... seal for best practices in meeting needs in ... materials and goods that meet strict criteria and ... by autism often have unique physical or psychological ... in food and medicine – for instance casein, ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... 2011 IOD Incorporated, a leading provider of integrated ... today announced it has received the federal ... Meaningful Use certification of its PRISM platform for both ... deems the software capable of enabling providers to qualify ...
... Arecor Limited has entered into ... to assess Arecor,s advanced protein formulation technologies for ... drugs.  Under this agreement, Arecor will develop stable ... and peptide drug candidates developed by Lilly.  In addition, ...
Cached Medicine Technology:IOD Incorporated's PRISM™ Receives ONC-ATCB Certification by Drummond Group 2IOD Incorporated's PRISM™ Receives ONC-ATCB Certification by Drummond Group 3Arecor Forms Collaboration With Lilly to Develop Advanced Formulations of Protein Therapeutics 2
... The RapidAMP test is an immunochromatography ... It is,designed for qualitative determination of ... cut-off level of 1000 ng/mL. This ... the point of care,location and is ...
The RapidBARBITURATE test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of barbiturates and in human urine specimens above a cut-off level of 3...
... ACL TOP is a fully ... volume labs maximize labor resources and ... provides clotting, chromogenic and immunoturbidimetric testing ... routine and specialty assays. It's also ...
... Quality Analysis System) developed by Pablo Artal, ... first diagnostic tool for ophthalmology that provides ... system. Never before has an ophthalmologist had ... quality of vision. , ,OQAS works by ...
Medicine Products: